TransPharma Medical TransPharma Medical    |    Home    |    Contact Us    |   
 About
 Technology
 ViaDerm System
 Drug Product Portfolio
 Potential Product
 Applications
 Strategic Partnerships
 Publications
 News & Events
In the News    |    Press Releases    |    Events    |     
News & Events | Press Releases
   
TransPharma Medical Completes $18 Million Series C Financing
Funding led by Argonaut with backing from Teva and current investors
  TransPharma Medical Ltd., a specialty pharmaceutical company focused on the development and commercialization of drug products utilizing a proprietary active transdermal drug delivery technology, today announced that it has secured $18 million in Series C financing.
July 24, 2006
Read more

 
Transpharma Medical Recieves First Milestone Payment From TEVA Pharmaceuticals
  TransPharma-Medical Ltd., has received its first milestone payment from Teva Pharmaceuticals.
May 1, 2006
Read more

 
Transpharma-Medical To Announce Promising Results of Clinical Trials With its hPTH (1-34) - Transdermal Delivery Product For Osteoporosis Treatment
  TransPharma-Medical Ltd., the Israeli-based specialty pharma company announces promising results of first human clinical trials.
March 29, 2006
Read more

 
Back to Top  

Terms of Use
   

© TransPharma Medical™ Ltd. All Rights Reserved.
updated Aug 2008